Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Myriad Genetics Inc (MYGN)  
$25.29 0.68 (2.76%) as of 4:30 Fri 5/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,542,000
Market Cap: 2.39(B)
Last Volume: 598,558 Avg Vol: 696,407
52 Week Range: $13.91 - $25.47
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  618
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 234,044 264,044 272,682 343,723
Total Sell Value $5,885,623 $6,458,458 $6,657,218 $8,073,398
Total People Sold 2 3 4 5
Total Sell Transactions 4 5 6 13
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 1307
  Page 24 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Best Lawrence C Director   –       •      –    2015-12-03 4 A $0.00 $0 D/D 7,500 17,500     -
   Gilbert Walter Phd Director   –       •      –    2015-12-03 4 A $0.00 $0 D/D 7,500 17,500     -
   Dreismann Heinrich Director   –       •      –    2015-12-03 4 A $0.00 $0 D/D 7,500 17,500     -
   Langer Dennis Director   –       •      –    2015-12-03 4 A $0.00 $0 D/D 7,500 17,500     -
   Henderson John T Director   –       •      –    2015-12-03 4 A $0.00 $0 D/D 7,500 21,500     -
   Dreismann Heinrich Director   –       •      –    2015-11-05 4 S $44.44 $2,666,118 D/D (60,000) 10,000     -
   Dreismann Heinrich Director   –       •      –    2015-11-05 4 OE $25.39 $1,590,000 D/D 60,000 40,000     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2015-11-04 4 AS $44.50 $1,557,500 D/D (35,000) 68,384     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2015-11-04 4 OE $22.93 $802,550 D/D 35,000 103,384     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2015-11-04 4 GD $0.00 $0 D/D 1,739 68,384     -
   King Gary A. Exec. VP International Ops   •       –      –    2015-10-28 4 AS $42.82 $428,200 D/D (10,000) 80,573     -
   King Gary A. Exec. VP International Ops   •       –      –    2015-10-28 4 OE $23.98 $239,800 D/D 10,000 90,573     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-28 4 AS $41.86 $2,133,269 D/D (50,962) 70,737     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-28 4 OE $22.93 $1,168,559 D/D 50,962 121,699     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-27 4 AS $41.80 $515,645 D/D (12,336) 70,737     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-27 4 OE $16.53 $236,157 D/D 12,336 75,775     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-26 4 AS $41.80 $480,324 D/D (11,491) 70,737     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-26 4 OE $16.53 $189,946 D/D 11,491 82,228     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-23 4 AS $41.80 $39,292 D/D (940) 70,737     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2015-10-23 4 OE $16.53 $15,538 D/D 940 71,677     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2015-10-21 4 GD $0.00 $0 D/D 2,628 70,123     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2015-10-17 4 D $39.31 $95,405 D/D (2,427) 27,573     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2015-10-06 4 OE $16.53 $187,821 D/D 6,208 72,751     -
   Mcdade Ralph L President Myriad RBM, Inc.   •       –      –    2015-09-17 4 D $41.39 $90,561 D/D (2,188) 55,157     -
   King Gary A. Exec. VP International Ops   •       –      –    2015-09-17 4 D $41.39 $223,506 D/D (5,400) 80,573     -
  1307 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 24 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us